Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

The design of prostheses has significantly evolved thanks to advances in biomechanics and computational simulation. Traditionally, the development of these ...

Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves ...

This video highlights the latest innovations and advancements in modern technologies, showcasing remarkable inventions that ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following ...

MIT researchers have developed a new bionic knee that can help people with above-the-knee amputations walk faster, climb ...

Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.

Vor Bio is licensing global rights to a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last ...

Meanwhile, biotech veteran Jean-Paul Kress, M.D. has stepped in as CEO and Chairman of the company, replacing Dr. Robert Ang, who will stay on as a strategic advisor through October.